Estradiol attenuates directed migration of vascular smooth muscle cells in vitro

American Journal of Pathology

Volumn 148, Issue 3, 1996, Pages 969-976

  Kolodgie, Frank D ^a   Jacob, Anup ^a   Wilson, Patricia S ^a   Carlson, Greg C ^a   Farb, Andrew ^a   Verma, Ajay ^b   Virmani, Renu ^a  

^a ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

^b UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIDE; ANTIESTROGEN; DACTINOMYCIN; DIETHYLSTILBESTROL; DRUG DERIVATIVE; ESTRADIOL; N BUTYL 11 (3,17BETA DIHYDROXYESTRA 1,3,5(10) TRIEN 7ALPHA YL) N METHYLUNDECANAMIDE; TESTOSTERONE;

ANIMAL; ARTICLE; CELL CULTURE; CELL MOTION; CYTOLOGY; DRUG EFFECT; FEMALE; GENETIC TRANSCRIPTION; PHYSIOLOGY; RAT; SPRAGUE DAWLEY RAT; VASCULAR SMOOTH MUSCLE;

ANIMALS; CELL MOVEMENT; CELLS, CULTURED; DACTINOMYCIN; DIETHYLSTILBESTROL; ESTRADIOL; ESTROGEN ANTAGONISTS; FEMALE; MUSCLE, SMOOTH, VASCULAR; POLYUNSATURATED ALKAMIDES; RATS; RATS, SPRAGUE-DAWLEY; TESTOSTERONE; TRANSCRIPTION, GENETIC;

EID: 0030091218     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Wren BG: The effect of oestrogen on the female cardiovascular system. Med J Aust 1992, 157:204-208
2. Barrett-Connor E, Bush TL: Estrogen and coronary heart disease in women. JAMA 1991, 265 1861-1867
3. Stampfer MJ, Colditz GA. Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence Prev Med 1991, 20 47-63
4. Stampfer MJ, Willett WC, Colditz GA, Rosner B, Speizer FE, Hennekens CH: A prospective study of postmenopausal estrogen therapy and coronary heart disease. N Engl J Med 1985, 313.1044-1049
5. Colditz GA, Willett WC, Stampfer MJ, Rosner B, Speizer FE. Hennekens CH Menopause and risk of coronary heart disease in women. N Engl J Med 1987, 316. 1105-1110
6. Adams MR, Kaplan JR, Manuck SB, Koritnik DR, Parks JS, Wolfe MS, Clarkson TB. Inhibition of coronary artery atherosclerosis by 17-β estradiol in ovanectomized monkeys: lack of an effect of added progesterone. Arteriosclerosis 1990, 10:1051-1057
7. Kushwaha RS, Lewis DS, Carey KD, McGill HC Jr Effects of estrogen and progesterone on plasma lipoproteins and experimental atherosclerosis in the baboon (Papio sp) Arterioscler Thromb 1991, 11:23-31
8. Haarbo J, Leth-Espensen P, Stender S, Christiansen C. Estrogen monotherapy and combined estrogen-progestogen replacement therapy attenuate aortic accumulation of cholesterol in ovariectomized cholesterolfed rabbits J Clin Invest 1991, 87:1274-1279
9. Nakao J, Chang WC, Murota SI, Orimo H: Estradiol-binding sites in rat aortic smooth muscle cells in culture. Atherosclerosis 1981, 38:75-80
10. Orimo A, Inoue S, Ikegami A, Hosoi T, Akishita M, Ouchi Y, Muramatsu M, Orimo H. Vascular smooth muscle cells as target for estrogen. Biochem Biophys Res Commun 1993, 15 730-736
11. Losordo DW, Kearney M, Kim EA, Jekanowski J, Isner JM. Variable expression of the estrogen receptor in normal and atherosclerotic coronary arteries of premenopausal women. Circulation 1994, 89:1501-1510
12. Karas RH, Patterson BL, Mendelsohn ME. Human vascular smooth muscle cells contain functional estrogen receptor Circulation 1994, 89:1943-1950
13. Colburn P, Buonassisi V: Estrogen-binding sites in endothelial cell cultures Science 1978, 201 817-819
14. Vargas R, Wroblewska B, Rego A, Hatch J, Ramwell PW. Oestradiol inhibits smooth muscle cell proliferation of pig coronary artery Br J Pharmacol 1993, 109.612-617
15. Foegh ML, Asotra S, Howell MH, Ramwell PW: Estradiol inhibition of arterial neointimal hyperplasia after balloon angioplasty J Vasc Surg 1994, 19.722-726
16. Ross R: The pathogenesis of atherosclerosis: a perspective for the 1990s Nature 1993, 362:801-809
17. Raines EW, Ross R. Smooth muscle cells and the pathogenesis of the lesions of atherosclerosis Br Heart J 1993, 69(Suppl. 1).S30-S37
18. Cole OF, Fan TP, Lewis GP. Isolation, characterization, growth and culture of endothelial cells from rat aorta. Cell Biol Int Rep 1986, 10:399-405
19. Spaet TH, Stemerman MB, Veith FJ, Lejnieks I: Intimal injury and regrowth in the rabbit aorta, medial smooth muscle cells as a source of neointima. Circ Res 1975, 36.58-70
20. Wagner DD, Marder VJ. Biosynthesis of von Willebrand protein by human endothelial cells, processing steps and their intracellular location. J Cell Biol 1984, 99: 2123-2130
21. Berthois Y, Katzenellenbogen JA, Katzenellenbogen BS Phenol red in tissue culture media is a weak estrogen. implications concerning the study of estrogen-responsive cells in culture Proc Natl Acad Sci USA 1986, 83 2496-2500
22. Thompson EW, Katz D, Shima TB, Wakeling AE, Lippman ME, Dickson RB: ICI 164,384, a pure antagonist of estrogen-stimulated MCF-7 cell proliferation and invasiveness. Cancer Res 1989, 49 6929-6934
23. Shimokado K, Yokota T, Umezawa K, Sasaguri T, Ogata J Protein tyrosine kinase inhibitors inhibit chemotaxis of vascular smooth muscle. Arterioscler Thromb 1994, 14:973-981
24. Dauvois S, Danielian PS, White R, Parker MG: Antiestrogen ICI 164,384 reduces cellular estrogen receptor content by increasing its turnover. Proc Natl Acad Sci USA 1992, 89 4037-4041
25. Mendelsohn ME, Karas R: Estrogen and the blood vessel wall. Curr Opin Cardiol 1994, 9:619-626
26. Rosano GM, Sarrel PM: Ovarian hormones and the cardiovascular system: recent findings. Cardiologia 1994, 39:275-279
27. Clowes AW, Schwartz SM Significance of quiescent smooth muscle migration in the injured rat carotid artery. Circ Res 1985, 56 139-145
28. Fischer-Dzoga K, Wissler RW, Vesselinovitch D The effect of estradiol on the proliferation of rabbit aortic medial tissue culture cells induced by hyperlipidemic serum Exp Mol Pathol 1983, 39:355-363
29. Farhat MY, Vargas R, Dingaan B, Ramwell PW In vitro effect of oestradiol on thymidine uptake in pulmonary vascular smooth muscle cell: role of endothelium. Br J Pharmacol 1992, 107.679-683
30. Jackson CL, Raines EW, Ross R, Reidy MA: Role of endogenous platelet-derived growth factor in arterial smooth muscle cell migration after balloon injury. Arterioscler Thromb 1993, 13.1218-1226
31. Grotendorst GR, Chang T, Seppa HE, Kleinman HK, Martin GR: Platelet-derived growth factor is a chemoattractant for vascular smooth muscle J Cell Physiol 1982, 113.261-266
32. Koyama N, Koshikawa T, Morisaki N, Saito Y, Yoshida S Bifunctional effects of transforming growth factor-β on migration of cultured rat aortic smooth muscle cells. Biochem Biophys Res Commun 1990, 169:725-729
33. Koyama N, Morisaki N, Saito Y, Yoshida S: Regulatory effects of platelet-derived growth factor-AA homodimer on migration of vascular smooth muscle cells. J Biol Chem 1992, 267 22806-22812
34. Yue TL, Wang X, Sung CP, Olson B, McKenna PJ, Gu JL, Feuerstein GZ: Interleukin-8: a mitogen and chemoattractant for vascular smooth muscle cells. Circ Res 1994, 75:1-7
35. Jawien AD, Bowen-Pope DF, Linder V, Schwartz SM, Clowes AW. Platelet-derived growth factor promotes smooth muscle migration and intimal thickening in a rat model of balloon angioplasty. J Clin Invest 1992, 89 507-511
36. Fingerle J, Johnson R, Clowes AW, Majesky MW, Reidy MA. Role of platelets in smooth muscle cell proliferation and migration after vascular injury in the rat carotid artery. Proc Natl Acad Sci USA 1989, 86 8412-8416
37. Ferns GA, Raines EW, Sprugel KH, Montani AS, Reidy MA, Ross R Inhibition of neointimal smooth muscle cell accumulation after angioplasty by an antibody to PDGF. Science 1991, 253 1129-1132
38. Hoedemaker M, Lund LA Wagner WC Influence of arachidonic acid metabolites and steroids on the function of bovine polymorphonuclear neutrophils. Am J Vet Res 1992, 53:534-1539
39. Morales DE, McGowan KA, Grant DS, Maheshwan S. Bhartiya D, Cid MC, Kleinman HK, Schnaper HW: Estrogen promotes angiogenic activity in human umbilical vein endothelial cells in vitro and in a murine model. Circulation 1995, 91:755-763
40. Bakerman S: ABC's of Interpretive Laboratory Data, ed 2. Greenville, NC, Interpretive Laboratory Data, 1984
41. Chang WC, Nakao J, Orimo H, Murota S: Stimulation of prostacyclin biosynthesis activity by estradiol in rat aortfc smooth muscle cells in culture Biochem Biophys Acta 1980, 619:107-118
42. Ignar-Trowbridge DM, Teng CT, Ross KA, Parker MG, Korach KS, McLachlan JA: Peptide growth factors elicit estrogen receptor-dependent transcriptional activation of an estrogen-responsive element. Mol Endocrinol 1993, 7:992-998
43. Wakeling AE: Use of pure antioestrogens to elucidate the mode of action of oestrogens Biochem Pharmacol 1995, 49:1545-1549
44. Gibson MK, Nemmers LA, Beckman WC Jr, Davis VL, Curtis SW, Korach KS. The mechanism of ICI 164,384 antiestrogenicity involves rapid loss of estrogen receptor in uterine tissue. Endocrinology 1991, 129:2000-2010
45. Dauvois S, White R, Parker MG: The antiestrogen ICI 182,780 disrupts estrogen receptor nucleocytoplasmic shuttling. J Cell Sci 1993, 106:1377-1388
46. Seppa H, Grotendorst G, Seppa S, Schiffmann E, Martin GR Platelet-derived growth factor is chemotactic for fibroblasts J Cell Biol 1982, 92:584-588
47. Chang FV, Shaio MF. In vitro effect of actinomycin D on human neutrophil function Microbiol Immunol 1990, 34:311-321
48. Gallin JI, Wright DG, Schiffmann E Role of secretory events in modulating human neutrophil chemotaxis. J Clin Invest 1978, 62.1364-1374
49. Cairo MS, Mallett C, VandeVen C, Kempert P, Bennetts GA, Katz J Impaired in vitro polymorphonuclear function secondary to the chemotherapeutic effects of vincristine, adriamycin, cyclophosphamide, and actinomycin D. J Clin Oncol 1986, 4.798-804
50. Bornfeldt KE, Raines EW, Nakano T, Graves LM, Krebs EG, Ross R Insulin-like growth factor-1 and platelet-derived growth factor-BB induce directed migration of human arterial smooth muscle cells via signaling pathways that are distinct from those of proliferation. J Clin Invest 1994, 93:266-1274
51. Bornfeldt KE, Graves LM, Raines EW, Igarashi Y, Wayman GH, Yamamura S, Yatomi Y, Sidhu JS, Krebs EG, Hakamori S, Ross R Sphingosine-1-phosphate inhibits PDGF-induced chemotaxis of human arterial smooth muscle cells: spatial and temporal modulation of PDGF chemotactic signal transduction. J Cell Biol 1995, 130: 193-206